Product information

Current status:

Cancelled Pre Market

Current status date:

2022-01-12

Original market date: ^{See footnote 1}

1994-12-31

Product name:

DIMENHYDRINATE INJECTION, USP

DIN:

02061732 Electronic product monograph is not available

Company:

MYLAN PHARMACEUTICALS ULC
85 Advance Road
Etobicoke
Ontario
Canada M8Z 2S6

Class:

Human

Dosage form(s):

Solution

Route(s) of administration:

Intravenous ,  Intramuscular

Number of active ingredient(s):

1

Schedule(s):

Ethical

American Hospital Formulary Service (AHFS): ^{See footnote 3}

56:22.08 

Anatomical Therapeutic Chemical (ATC): ^{See footnote 4}

R06AA11 DIMENHYDRINATE

Active ingredient group (AIG) number:^{See footnote5}

0102747004